Determination of the biological activity of Nhe by measuring the decrease in light from the luciferase reaction as a result of inhibition of luciferase enzyme synthesis. by Reuven Rasooly (394508)

Table_1_Decreasing the carbon footprint of food through public procurement—A case study from the municipality of Härnösand.XLSX by Mari Kjellberg (20130183)

Ryanodine treated growth cones do not respond to the biophysical microfeatures while xestospongin C treated turn at a decreased frequency. by Joseph T. Vecchi (16879587)

DataSheet_1_Fecal microbiota in patients with a stoma decreases anaerobic bacteria and alters taxonomic and functional diversities.docx by Shunsuke A. Sakai (13789939)

Supplementary Material for: Platelet Decreases following Continuous Renal Replacement Therapy Initiation as a Novel Risk Factor for Renal Nonrecovery by Griffin B.R. (8570007)

Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

Reducing Dscam1 diversity decreases adult lifespan in a cluster-specific manner, also see S6 and S7 Figs. by Haiyang Dong (4783608)

DataSheet_1_Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels.xlsx by Murielle Golomingi (13239774)

Discovery of Betulinic Acid Derivatives as Potent Intestinal Farnesoid X Receptor Antagonists to Ameliorate Nonalcoholic Steatohepatitis by Chenlu Zhang (508309)

“…Evidence showed that intestinal FXR antagonism exhibited remarkable metabolic improvements in mice. Herein, we developed a series of betulinic acid derivatives as potent intestinal FXR antagonists, and <b>F6</b> was identified as the most potent one with an IC₅₀ at 2.1 μM. …”

Discovery of Betulinic Acid Derivatives as Potent Intestinal Farnesoid X Receptor Antagonists to Ameliorate Nonalcoholic Steatohepatitis by Chenlu Zhang (508309)

“…Evidence showed that intestinal FXR antagonism exhibited remarkable metabolic improvements in mice. Herein, we developed a series of betulinic acid derivatives as potent intestinal FXR antagonists, and <b>F6</b> was identified as the most potent one with an IC₅₀ at 2.1 μM. …”

Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf by Yi Li (1144)

“…Compared to the control group, the prehospital TXA group exhibited a significant reduction in 24-h mortality with an OR of 0.72 and a 95% CI of 0.54–0.94 (p = 0.02), while no statistically significant difference in the incidence of venous thromboembolism (VTE; OR: 1.14, 95% CI: 0.98–1.33, p = 0.09). …”

Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients. by Káryta Suely Macêdo Martins (22404155)

Linear mixed effects model estimates of the relationship between physical activity and alpha-diversity. by Elizabeth A. Holzhausen (14014275)

Results of negative binomial models, before and after adjustment for multiple testing. by Elizabeth A. Holzhausen (14014275)

Summary of missing accelerometery data. by Elizabeth A. Holzhausen (14014275)

Descriptive sample characteristics, Survey of the Health of Wisconsin, 2016–2017. by Elizabeth A. Holzhausen (14014275)

Bray-Curtis dissimilarity distances, colored by measures of physical activity. by Elizabeth A. Holzhausen (14014275)

Linear mixed effects model estimates of the relationship between physical activity and alpha-diversity, summary of models with interaction. by Elizabeth A. Holzhausen (14014275)

Estimated means and confidence intervals of playing style variables according to the team’s ranking at the end of the season in <i>LaLiga</i> from 2008/09 to 2020/21 after adjustin... by Joaquín González-Rodenas (8463846)

Kaplan-Meier estimates of the duration of action of BTX-A treatment. by Parima Hirunwiwatkul (14797370)